Findings

What do systematic reviews say?

415 questions · 442 findings · 58 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 70 · 15.8%GRADE not reported 19 · 4.3%Very low 99 · 22.4%Low 137 · 31%Moderate 86 · 19.5%High 31 · 7%

Corticosteroids vs placebo

Length of hospital stay · Pregnant women with hyperemesis gravidarum

1 finding from 1 review

Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 110 participants
Very low

Corticosteroids vs placebo

Pregnancy complications · Pregnant women with hyperemesis gravidarum

It is very uncertain whether corticosteroids changes pregnancy complications compared with placebo (very low certainty).

1 finding from 1 review

Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
RR 0.61 [0.26, 1.47]
1 study · 110 participants
Very low

Corticosteroids vs placebo

Spontaneous abortion · Pregnant women with hyperemesis gravidarum

It is very uncertain whether corticosteroids changes spontaneous abortion compared with placebo (very low certainty).

1 finding from 1 review

Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
RR 0.64 [0.11, 3.7]
1 study · 110 participants
Very low

Corticosteroids vs placebo

Perinatal mortality · Pregnant women with hyperemesis gravidarum

It is very uncertain whether corticosteroids changes stillbirth and neonatal death compared with placebo (very low certainty).

1 finding from 1 review

Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
RR 0.7 [0.15, 3.34]
2 studies · 134 participants
Very low

Corticosteroids vs placebo

Congenital abnormalities · Pregnant women with hyperemesis gravidarum

It is very uncertain whether corticosteroids changes congenital abnormalities compared with placebo (very low certainty).

1 finding from 1 review

Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
RR 0.32 [0.01, 7.73]
1 study · 110 participants
Very low

Corticosteroids vs placebo

Side effects · Pregnant women with hyperemesis gravidarum

It is very uncertain whether corticosteroids changes intervention side effects compared with placebo (very low certainty).

1 finding from 1 review

Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
RR 0.79 [0.06, 11.2]
1 study · 25 participants
Very low

Corticosteroids vs placebo

Preterm birth · Pregnant women with hyperemesis gravidarum

It is very uncertain whether corticosteroids changes preterm birth compared with placebo (very low certainty).

1 finding from 1 review

Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
RR 1.01 [0.31, 3.28]
2 studies · 134 participants
Very low

Corticosteroids vs placebo

Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Quality of life outcomes · Pregnant women with hyperemesis gravidarum

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating hyperemesis gravidarum 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Corticosteroids vs placebo compared

Death ‐ at 180 days after ICU admission, in total population randomised · critically ill patients

Corticosteroids showed no clear difference in death ‐ death at 180 days in total population randomised compared with placebo compared (high certainty).

1 finding from 1 review

Interventions for preventing critical illness polyneuropathy and critical illness myopathy 2014 · Cochrane Headline outcomes only
RR 0.99 [0.64, 1.52]
1 study · 180 participants
High

Corticosteroids vs placebo compared

Serious adverse events (dichotomous data) ‐ shock · critically ill patients

Corticosteroids showed no clear difference in serious adverse events (dichotomous data) ‐ shock compared with placebo compared (high certainty).

1 finding from 1 review

Interventions for preventing critical illness polyneuropathy and critical illness myopathy 2014 · Cochrane Headline outcomes only
RR 0.41 [0.17, 1.01]
1 study · 180 participants
High

Corticosteroids vs placebo compared

Serious adverse events (dichotomous data) ‐ serious infection · critically ill patients

Corticosteroids showed no clear difference in serious adverse events (dichotomous data) ‐ serious infection compared with placebo compared (high certainty).

1 finding from 1 review

Interventions for preventing critical illness polyneuropathy and critical illness myopathy 2014 · Cochrane Headline outcomes only
RR 0.68 [0.42, 1.11]
1 study · 180 participants
High

Corticosteroids vs placebo compared

Serious adverse events (dichotomous data) ‐ suspected or probable pneumonia · critically ill patients

Corticosteroids showed no clear difference in serious adverse events (dichotomous data) ‐ suspected or probable… compared with placebo compared (high certainty).

1 finding from 1 review

Interventions for preventing critical illness polyneuropathy and critical illness myopathy 2014 · Cochrane Headline outcomes only
RR 0.44 [0.18, 1.09]
1 study · 180 participants
High

Corticosteroids vs placebo compared

Serious adverse events (continuous data) ‐ blood glucose (mg/dL) on day 7 · critically ill patients

1 finding from 1 review

Interventions for preventing critical illness polyneuropathy and critical illness myopathy 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 180 participants
High

Corticosteroids vs placebo compared

Occurrence of CIP/CIM ‐ in the total population randomised · critically ill patients

Corticosteroids showed no clear difference in occurrence of CIP/CIM ‐ in total population randomised compared with placebo compared (low certainty).

1 finding from 1 review

Interventions for preventing critical illness polyneuropathy and critical illness myopathy 2014 · Cochrane Headline outcomes only
RR 1.27 [0.77, 2.08]
1 study · 180 participants
Low

Corticosteroids vs placebo compared

Occurrence of CIP/CIM ‐ in screened population · critically ill patients

Corticosteroids showed no clear difference in occurrence of CIP/CIM ‐ in screened population compared with placebo compared (moderate certainty).

1 finding from 1 review

Interventions for preventing critical illness polyneuropathy and critical illness myopathy 2014 · Cochrane Headline outcomes only
RR 1.09 [0.53, 2.26]
1 study · 92 participants
Moderate

Corticosteroids vs placebo

Number of children with clinical adverse event: vertigo · Patients with idiopathic acute vestibular dysfunction (vestibular neuritis)

Corticosteroids showed no clear difference in vertigo compared with placebo (low certainty).

1 finding from 1 review

Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
RR 0.39 [0.04, 3.57]
2 studies · 60 participants
Low

Corticosteroids vs placebo

Dizziness Handicap Inventory score · Patients with idiopathic acute vestibular dysfunction (vestibular neuritis)

1 finding from 1 review

Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Low

Corticosteroids vs placebo

Caloric extent of recovery (improvement as a % in lateralisation of electronystagmography on caloric testing) · Patients with idiopathic acute vestibular dysfunction (vestibular neuritis)

2 findings from 1 review

Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Low
Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 89 participants
Low

Corticosteroids vs placebo

Complete caloric recovery · Patients with idiopathic acute vestibular dysfunction (vestibular neuritis)

Corticosteroids may leads to higher complete caloric recovery compared with placebo (low certainty).

2 findings from 1 review

Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
RR 2.81 [1.32, 6]
2 studies · 50 participants
Low
Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
RR 1.58 [0.45, 5.62]
2 studies · 89 participants
Low

Corticosteroids vs placebo

Adverse effects · Patients with idiopathic acute vestibular dysfunction (vestibular neuritis)

1 finding from 1 review

Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 73 participants
Moderate